in-PharmaTechnologist presents its latest roundup of appointments in the pharmaceutical sector, including movements at UCB Pharma Canada and a resignation at GeoVax.
US biotechnology group OSI Pharmaceuticals will move HQ to a facility in Greenburgh, New York due, according to observers, to the high cost of land at its current base in Long Island.
Outsourcing-Pharma presents its latest round up of movements in the pharmaceutical outsourcing sector, including appointments at Covance, Sundia MediTech and Cardinal.
Novartis and Jubilant Organosys are among several companies forced to recall generic drugs after manufacturing operations at their shared CMO, India’s MJ Biopharm, were found to be in breach of GMP guidelines.
UK contracting group Pharmaceutical Development Services (PDS) has set up an office in North Carolina, US to court North America pharma firms for the European development sector.
Sanofi-Aventis has moved to defend its long-acting diabetes treatment Lantus (insulin glargine) and says that recent research linking it to the development of cancer is of “poor quality.”
Outsourcing-Pharma presents its latest round up of movements in the pharmaceutical outsourcing sector, including appointments at WuXi, OctoPlus and Catalent.
Mylan has followed Teva’s lead by partnering to develop follow-on biologics (FOB), with the Indian generic maker regarding Biocon as the “ideal partner” to help it enter the market.
in-PharmaTechnologist presents its latest round up of appointments in the pharmaceutical sector, including Lilly’s CEO taking a role at Nike and Takeda’s illustrious global advisory board.
Regulatory agencies are putting increased emphasis on transparency, with the FDA holding its first public meeting on the topic and the EMEA seeking feedback from citizens on its draft policy.
Outsourcing-Pharma presents its latest round up of movements in the pharmaceutical outsourcing sector, including appointments at WuXi, Dishman and Sartorius Stedim.
The growth of the Chinese vaccine market is set to outstrip the country’s pharma sector, according to a Frost & Sullivan (F&S) report that predicts 14-15 per cent CAGR.
The number of pharma employees in New Jersey, US fell by 1,400 in 2008, with R&D expenditure, capital investment and product trials also declining, according to a report.
Watson Pharmaceuticals is to acquire Arrow Group for $1.75bn (€1.26bn), adding to the company’s manufacturing network and providing it with the expertise needed to enter the biogenerics market.
As rumours of a failed Sanofi Aventis’ bid for a US rival circulate, F&S’ analysis of M&As is well timed, even if its conclusions will be difficult reading for a Big Pharma sector set on replenishing pipelines via big deals.
Large pharma companies will increase the level of supply chain activities they outsource in the next few years but smaller businesses are predicted to keep them in-house, according to a report.
in-PharmaTechnologist presents its latest round up of appointments in the pharmaceutical sector, including a former mayor joining Eli Lilly and new CEOs at three companies.
Swiss life sciences solutions firm Lonza has been contracted by US biotechnology group Elusys Therapeutics to produce Anthim, its late stage Ab candidate treatment for anthrax infection.
Outsourcing-Pharma provides its latest round up of movements in the pharmaceutical outsourcing sector, including changes to AMRI’s leadership in India and a new VP at Covance.
The GAVI Alliance has launched an advance market commitment (AMC), which is using a $1.5bn (€1.1bn) fund to ensure the supply of pneumococcal vaccine to developing countries at affordable prices.
The United Arab Emirates (UAE) is looking to establish itself as a prime location for pharmaceutical companies, with “massive amounts of money and huge incentives” being used to attract business.
The US Federal Trade Commission (FTC) believes that an effective FOB approval pathway and laws preventing “pay-for-delay” deals are the only ways of reducing the cost of biologic drugs.
Satyam, the Indian IT outsourcing company whose former chairman admitted to a $1bn (€700m) fraud in January, has posted a $10.9m unaudited profit for February, sending shares soaring.
UK drug major GSK has had a busy week in the Asia, signing an influenza vaccine manufacturing deal with China’s Shenzhen Neptunus Interlong Bio-Technique just days after it opened a new S$600m (EUR294m) production facility in Singapore.
In response to eClinical opportunities TechTeam has established a global life sciences business unit, which it believes can grow “at an aggressive rate”.
Swedish CRO Syntagon has set up an office in Shanghai, China to forge stronger links with a broader range of local raw materials suppliers, saving its customers time and money.
Sanofi Aventis will pay Pfizer €30m ($41m) for a former Exubera manufacturing plant in Frankfurt-Höchst, Germany that was due to be bought by inhaled insulin specialist MannKind.
in-PharmaTechnologist presents its latest round up of appointments in the pharmaceutical sector, including media reports of a new CEO at Proctor & Gamble.
PDI has entered into a strategic alliance with The Medical Affairs Company (TMAC) to offer “a more complete set of field-based commercialisation solutions”.
Don’t miss this video interview with Robert Marr, chief operating officer of William Reed Business Media which recently acquired Decision News Media publisher of CosmeticsDesign-Europe.com and CosmeticsDesign.com.
IT solutions firm Merge Healthcare has won the race to buy eClinical specialist etrials, beating previous suitor Bio-Imaging Technologies whose takeover bid collapsed on Monday.
GE Healthcare hopes its new modular validation platform (MVP) will change the way drugmakers think about how they create new plants and bring existing manufacturing facilities up to code.
Industrial automation specialist Emerson Process Management has won the contract to help Swiss life sciences group Lonza design its new biopharmaceuticals plant in Singapore.
PRA International has opened a drug safety centre in São Paulo, Brazil, expanding its presence in Latin America and bringing its array of services to a new market.
Power outages cost India $9.2bn (€6.5bn) in 2008, according to a report, with the disruptions causing direct losses in numerous sectors, including pharma and biotech.
Decision News Media, publisher of Outsourcing-Pharma.com, in-PharmaTechnologist.com and 15 other websites serving the international food, nutrition, pharmaceutical and cosmetics industries, has been acquired by the leading UK business-to-business publisher...
GSK and Pfizer’s HIV joint venture (JV) may be subject to an investigation by UK competition watchdog the Office of Fair Trading (OFT), according to various media reports.
Outsourcing-Pharma provides its latest round up of movements in the pharmaceutical outsourcing sector, including an executive reshuffle at PPD that caused share price to dip.
Stiffer penalties for counterfeiters could be counterproductive in less developed countries (LDC) and “entrench the corrupt symbiotic relationship between counterfeiters, lawmakers and officials”, according to a report
in-Pharmatechnologist's Nick Taylor looks back on BIO 2009, an event at which uncertainty about the development of the biotechnology industry’s future shape dominated proceedings.
HEM Pierre Vimont, Ambassador of France to the US, was at BIO 2009 talking about the measures his nation have taken to attract biotechs, including the introduction of the "most favourable R&D tax in Europe".
